Personality Traits, Depression, and Objectively Measured Adherence to Once-daily Prostaglandin Analog Medication in Glaucoma

Holló, Gábor; Kóthy, Péter; Géczy, Anna; Vargha, P.

doi:10.1097/ijg.0b013e31818456b9

Cited by 33 publications

(18 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Self-report instruments per se have their limitations, such as respondent bias and errors in the recall of behavior [48]. In addition, in research designs using simple direct questions about medication that has possibly been forgotten, there is the potential for activating what the interviewee sees as socially desirable answer behavior [49,50]. More sophisticated NA self-report questionnaires use indirect, nonaccusatory questioning techniques to minimize the tendency to give socially desired answers.…”

Section: Introductionmentioning

confidence: 99%

Toward Identifying the Causes and Combinations of Causes Increasing the Risks of Nonadherence to Medical Regimens: Combined Results of Two German Self-Report Surveys

2011

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Toward Identifying the Causes and Combinations of Causes Increasing the Risks of Nonadherence to Medical Regimens: Combined Results of Two German Self-Report Surveys

2011

View full text Add to dashboard Cite

show abstract

“…The second limitation is that self-reporting has inherent weaknesses, the main one being a tendency of a patient to give favourable answers to please the physician. Hollo et al [23] measured the influence of psychological characteristics on compliance with glaucoma medication. They found that social desirability was significantly increased in a cohort of glaucoma patients as compared with normal subjects.…”

Section: Limitationsmentioning

confidence: 99%

Compliance and knowledge about glaucoma in patients at tertiary glaucoma units

et al. 2011

View full text Add to dashboard Cite

To document the rate of self-reported compliance and glaucoma-related knowledge in Swiss patients and to identify risk factors for their poor compliance. This was an observational study, including a total of 200 consecutive patients already under glaucoma medication in two Swiss tertiary glaucoma clinics (Geneva and Bern). Personal characteristics, presence of systemic disease, compliance with glaucoma medication, attitude to the ophthalmologist, and glaucoma-related attitudes were ascertained by means of a predetermined questionnaire with 40 questions. Patients were subsequently assessed for the ability to correctly instil placebo eye drops. Non-compliance with glaucoma medication was defined as omitting more than two doses a week as reported by the patient. Logistic regression was used to evaluate how patient characteristics and knowledge about the disease were related to compliance. Overall, 81% (n = 162) of patients reported to be compliant. Forgetfulness was the most frequently cited reason for non-compliance with dosing regimen (63%). Although 90.5% (n = 181) of patients believed glaucoma medication to be efficient, only 28% (n = 56) could correctly define glaucoma. Factors positively associated with compliance were 'knowledge of glaucoma' [adjusted odds ratio (OR) 4.77 (95% CI 1.36-16.70)] and 'getting help for administration of drops' ]. These findings indicate that despite the comparatively high compliance rate among glaucoma patients, knowledge of glaucoma remains poor in long-term glaucoma sufferers. Improving knowledge about the disease is important since it is positively associated with compliance in our study.

show abstract

“…Intraocular pressure (IOP)-lowering medication eye drops are typically prescribed for life-long use to slow the progression of the disease; however, the effectiveness of this treatment heavily depends on patient adherence to the regimen. 2–4 There are numerous barriers to glaucoma treatment adherence noted in the literature, including medication side effects, eye drop administration, literacy levels, and the complexity of medication regimens. 3, 5–8 …”

mentioning

confidence: 99%

Patient-Physician Communication on Medication Cost during Glaucoma Visits

et al. 2017

View full text Add to dashboard Cite

Significance This paper is the first to investigate the nature of medication cost discussions between ophthalmologists and glaucoma patients. Only 87 of the 275 office visits analyzed had a discussion of medication cost. Providers should consider discussing medication cost with patients to identify potential cost related barriers to medication use. Purpose Glaucoma is an incurable chronic eye disease affecting a growing portion of the aging population. Some of the most commonly utilized treatments require life-long use, requiring high patient adherence to ensure effectiveness. There are numerous barriers to glaucoma treatment adherence in the literature, including cost. The aim of this secondary analysis was to describe the frequency and nature of patient-physician communication regarding medication cost during glaucoma office visits. Methods: This was a mixed methods secondary analysis of video recorded participant office visits (n=275) from a larger observational study of glaucoma communication. We analyzed medical information, demographic characteristics, and interviewer-administrated questionnaires, as well as verbatim transcripts of interviews. Results Only 87 participants discussed medication cost during their glaucoma office visit. The majority of the subjects that discussed cost had mild disease severity (51%), took one glaucoma medication (63%) and had Medicare (49%) as well as a form of prescription insurance (78%). The majority of glaucoma office visits did not discuss medication cost and providers often did not ask about cost problems. Of the few conversations related to cost, most focused on providers offering potential solutions (n=50), medical and prescription service coverage (n=41), and brand or generic medication choices (n=41). Conclusions Our findings are similar to previous studies showing few patients have conversations with providers about the cost of glaucoma medications. Providers should consider bringing up medication cost during glaucoma office visits to prompt a discussion of potential cost related barriers to medication use.

show abstract

Personality Traits, Depression, and Objectively Measured Adherence to Once-daily Prostaglandin Analog Medication in Glaucoma

Cited by 33 publications

References 21 publications

Toward Identifying the Causes and Combinations of Causes Increasing the Risks of Nonadherence to Medical Regimens: Combined Results of Two German Self-Report Surveys

Toward Identifying the Causes and Combinations of Causes Increasing the Risks of Nonadherence to Medical Regimens: Combined Results of Two German Self-Report Surveys

Compliance and knowledge about glaucoma in patients at tertiary glaucoma units

Patient-Physician Communication on Medication Cost during Glaucoma Visits

Contact Info

Product

Resources

About